Ju‐Yeon Cho

Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma

Won Sohn, Jong‐Hwa Kim, So Hee Kang et al. · Experimental & Molecular Medicine · 2015 · 425 citations · Full text

Medicine, Molecular Biology, Oncology +17

Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease

Ju‐Yeon Cho, Yong‐Han Paik, Won Sohn et al. · Gut · 2014 · 171 citations

Pharmacy, Oncology, Pharmacotherapy +15

HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma

Won Sohn, Yong‐Han Paik, Jong Man Kim et al. · Annals of Surgical Oncology · 2014 · 120 citations

Medicine, Oncology, Hepatology +14

Clinical parameters predictive of outcomes in sorafenib‐treated patients with advanced hepatocellular carcinoma

Ju‐Yeon Cho, Yong‐Han Paik, Ho Yeong Lim et al. · Liver International · 2013 · 82 citations

Medicine, Oncology, Pharmacotherapy +17

Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A <scp>K</scp>orean multicenter retrospective study

Kang‐Moon Lee, Yoon Tae Jeen, Ju‐Yeon Cho et al. · Journal of Gastroenterology and Hepatology · 2013 · 77 citations

Pharmacy, Immunology, Pharmacotherapy +17